[Clinical aspects of immunosuppressive therapy in childhood rheumatoid arthritis].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000477:Alkylating Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001171:Arthritis, Juvenile / Q000188:drug therapy* / Q000276:immunology; D001379:Azathioprine / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D007111:Immunity, Cellular; D007165:Immunosuppression Therapy; D008727:Methotrexate / Q000627:therapeutic use*; D009369:Neoplasms / Q000139:chemically induced; D010396:Penicillamine / Q000627:therapeutic use*
D000305:Adrenal Cortex Hormones; D000477:Alkylating Agents; D010396:Penicillamine; D001379:Azathioprine; D008727:Methotrexate
Grundlagen und Praxis der immunsuppressiven Therapie bei rheumatoider Arthritis des Kindes.